Get the Stockscreener App
4.89
2.20%
-0.11
After Hours:
4.80
-0.09
-1.84%
Voyager Therapeutics Inc stock is traded at $4.89, with a volume of 718.66K.
It is down -2.20% in the last 24 hours and up +16.99% over the past month.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
See More
Previous Close:
$5.00
Open:
$5.1
24h Volume:
718.66K
Relative Volume:
0.93
Market Cap:
$271.24M
Revenue:
$163.78M
Net Income/Loss:
$25.88M
P/E Ratio:
7.5231
EPS:
0.65
Net Cash Flow:
$-28.66M
1W Performance:
-1.21%
1M Performance:
+16.99%
6M Performance:
+54.26%
1Y Performance:
-31.89%
1-Day Range:
$4.8242
$5.15
1-Week Range:
$4.60
$5.55
52-Week Range:
$2.645
$8.275
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Name
Voyager Therapeutics Inc
Sector
Industry
Phone
857-259-5340
Address
75 HAYDEN AVENUE, LEXINGTON, MA
Compare VYGR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
4.89 | 277.34M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-02-24 | Initiated | Citigroup | Buy |
| Nov-29-24 | Resumed | Wedbush | Outperform |
| Oct-16-24 | Initiated | Leerink Partners | Outperform |
| Mar-26-24 | Initiated | Guggenheim | Buy |
| Mar-19-24 | Initiated | H.C. Wainwright | Buy |
| Mar-07-24 | Initiated | Citigroup | Buy |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-10-23 | Initiated | Truist | Buy |
| Mar-10-23 | Initiated | Oppenheimer | Outperform |
| Oct-07-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-03-21 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-03-21 | Downgrade | Wedbush | Outperform → Neutral |
| Dec-24-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-23-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-11-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-10-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Nov-10-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-19-20 | Initiated | The Benchmark Company | Buy |
| Feb-06-20 | Initiated | Oppenheimer | Outperform |
| Nov-15-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| Sep-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-04-18 | Initiated | H.C. Wainwright | Buy |
| Mar-12-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-12-18 | Downgrade | Wedbush | Outperform → Neutral |
| Feb-02-18 | Initiated | Morgan Stanley | Overweight |
| Nov-28-17 | Resumed | Piper Jaffray | Overweight |
| Oct-31-17 | Initiated | Robert W. Baird | Outperform |
| Oct-27-17 | Initiated | Canaccord Genuity | Buy |
| Oct-23-17 | Reiterated | Stifel | Buy |
| Oct-12-17 | Initiated | Raymond James | Outperform |
| Aug-17-17 | Initiated | Evercore ISI | Outperform |
| Jul-28-17 | Resumed | Stifel | Buy |
View All
Voyager Therapeutics Inc Stock (VYGR) Latest News
Using portfolio simulators with Voyager Therapeutics Inc. includedJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Applying Elliott Wave Theory to Voyager Therapeutics Inc.Market Trend Review & Community Verified Watchlist Alerts - newser.com
Price action breakdown for Voyager Therapeutics Inc.IPO Watch & Reliable Breakout Forecasts - newser.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Is Voyager Therapeutics Inc a good long term investmentLow Risk Investment Ideas & High Return Portfolio Growth - earlytimes.in
What drives Voyager Therapeutics Inc stock priceEarnings Volatility Patterns & AI Alerts You Can Actually Trust - earlytimes.in
Exit strategy if you’re trapped in Voyager Therapeutics Inc.Quarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
How moving averages guide Voyager Therapeutics Inc. trading2025 Short Interest & Stock Market Timing Techniques - newser.com
Voyager Therapeutics (NASDAQ:VYGR) Earns Sell (D) Rating from Weiss Ratings - MarketBeat
Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Voyager Therapeutics (NASDAQ:VYGR) CFO Nathan Jorgensen Sells 7,666 Shares - MarketBeat
Is Voyager Therapeutics Inc. stock affected by interest rate hikesMarket Movement Recap & Community Supported Trade Ideas - newser.com
Why Momentum Traders Are Watching Glenmark Pharmaceuticals Limited Stock CloselyCandlestick Trading Patterns & Next-Level Stock Intelligence, Now Free - earlytimes.in
Oppenheimer Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛
Does Voyager Therapeutics Inc. show high probability of reboundQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Voyager Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & Superior Capital Appreciation - earlytimes.in
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Held Back By Insufficient Growth Even After Shares Climb 27% - simplywall.st
Strs Ohio Makes New Investment in Voyager Therapeutics, Inc. $VYGR - MarketBeat
Goldman Sachs Group Inc. Sells 67,877 Shares of Voyager Therapeutics, Inc. $VYGR - Defense World
Can Voyager Therapeutics Inc. hit a new high this monthJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
What recovery options are there for Voyager Therapeutics Inc.2025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Exit Recap: Is Voyager Therapeutics Inc stock a smart retirement pickJuly 2025 Analyst Calls & Safe Entry Point Identification - khodrobank.com
Pullback Watch: How does Voyager Therapeutics Inc compare to its peersPortfolio Risk Report & Verified High Yield Trade Plans - khodrobank.com
Aug Retail: Is DigiAsia Corp. currently under institutional pressureJuly 2025 Update & Reliable Entry Point Trade Alerts - khodrobank.com
Is Voyager Therapeutics Inc. trending in predictive chart modelsWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Voyager Therapeutics (NASDAQ:VYGR) Earns "Buy" Rating from HC Wainwright - MarketBeat
Market Fear: Can Voyager Therapeutics Inc continue delivering strong returnsMarket Sentiment Report & Technical Entry and Exit Alerts - khodrobank.com
Trading Recap: Can Voyager Therapeutics Inc continue delivering strong returnsAnalyst Downgrade & Growth Oriented Trade Recommendations - خودرو بانک
Inflation Data: Is Voyager Therapeutics Inc a stock for growth or value investorsCEO Change & AI Optimized Trading Strategy Guides - خودرو بانک
Buyout Rumor: Is Voyager Therapeutics Inc. subject to activist investor interest2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Combining price and volume data for Voyager Therapeutics Inc.Price Action & Safe Investment Capital Preservation Plans - newser.com
Will Voyager Therapeutics Inc. continue its uptrend2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
Aug Setups: How does FUFU correlate with NasdaqMarket Trend Report & Weekly Chart Analysis and Guides - خودرو بانک
Aug Spikes: Can Voyager Therapeutics Inc reach all time highs this year2025 Bull vs Bear & Free Community Consensus Stock Picks - خودرو بانک
Take Profit: Is Voyager Therapeutics Inc.’s growth already priced inEarnings Performance Report & Smart Swing Trading Alerts - خودرو بانک
When is the best time to exit Voyager Therapeutics Inc.Earnings Summary Report & Free Community Consensus Stock Picks - newser.com
Aug Wrap: Is Voyager Therapeutics Inc benefiting from innovation trendsMarket Risk Summary & Detailed Earnings Play Strategies - خودرو بانک
Merger Talk: Will Voyager Therapeutics Inc stock hit new highs in YEARJuly 2025 Weekly Recap & Risk Managed Investment Strategies - خودرو بانک
Aug Drivers: Should I invest in Voyager Therapeutics Inc before earningsJuly 2025 Catalysts & Trade Opportunity Analysis Reports - خودرو بانک
Voyager Therapeutics Inc Stock (VYGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):